510(k) K802886

NUCLI-PAP TM-(I125)-PAP RADIOIMMUNOAS- by Nuclear Diagnostics, Inc. — Product Code JFH

K802886 is an FDA 510(k) premarket notification submitted by Nuclear Diagnostics, Inc. for the device "NUCLI-PAP TM-(I125)-PAP RADIOIMMUNOAS-". The FDA issued a decision of Substantially Equivalent on January 28, 1981. The device falls under product code JFH (Acid Phosphatase (Prostatic), Tartrate Inhibited), a Class II device regulated under 21 CFR 862.1020. Nuclear Diagnostics, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 28, 1981
Date Received
November 17, 1980
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Acid Phosphatase (Prostatic), Tartrate Inhibited
Device Class
Class II
Regulation Number
862.1020
Review Panel
CH
Submission Type